Bezirgiannidou Z, Stamatiou I, Theodoridis TM, Kontekaki E, et al. Ravulizumab stabilizes life-threating intravascular hemolysis following delayed hemolytic transfusion reaction due to alloantibodies anti-e and anti-Jka: the first successful administration. Ann Hematol 2025;104:4849-4854.
PMID: 40875012